Guggenheim Capital’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-46,157
| Closed | -$1.12M | – | 2904 |
|
|
2017
Q1 | $1.12M | Buy |
46,157
+9,832
| +27% | +$238K | ﹤0.01% | 2048 |
|
|
2016
Q4 | $1.17M | Buy |
+36,325
| New | +$1.17M | ﹤0.01% | 2061 |
|
|
2016
Q3 | – | Sell |
-53,519
| Closed | -$2.27M | – | 2949 |
|
|
2016
Q2 | $2.27M | Buy |
53,519
+174
| +0.3% | +$7.38K | 0.01% | 1485 |
|
|
2016
Q1 | $3.51M | Sell |
53,345
-987
| -2% | -$65K | 0.01% | 1191 |
|
|
2015
Q4 | $3.38M | Sell |
54,332
-6,211
| -10% | -$386K | 0.01% | 1247 |
|
|
2015
Q3 | $4.05M | Sell |
60,543
-2,716
| -4% | -$182K | 0.01% | 1146 |
|
|
2015
Q2 | $6.16M | Buy |
63,259
+10,110
| +19% | +$984K | 0.02% | 1058 |
|
|
2015
Q1 | $4.97M | Buy |
53,149
+10,015
| +23% | +$936K | 0.01% | 1162 |
|
|
2014
Q4 | $3.84M | Buy |
+43,134
| New | +$3.84M | 0.01% | 1276 |
|